Phase I Study of Patupilone and RAD001

NCT00496600 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Refractory Malignancy

Interventions

DRUG: Patupilone
DRUG: RAD001

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]
[object Object]